Positron emission tomography in clinical neurology

Molecular Imaging and Biology

Volumn 6, Issue 4, 2004, Pages 239-269

  Herholz, Karl ^a   Heiss, W D ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Clinical neurology; FDG; Positron emission tomography (PET)

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMINO ACID; ANTINEOPLASTIC AGENT; BENZODIAZEPINE RECEPTOR; CARBON 11; DOPAMINE; FLUORINE; FLUORODEOXYGLUCOSE F 18; METHIONINE; NEUROTRANSMITTER; OXYGEN; TRACER; TYROSINE;

ALZHEIMER DISEASE; AMINO ACID TRANSPORT; ATAXIA; BENIGN CHILDHOOD EPILEPSY; BRACHYTHERAPY; BRAIN BLOOD FLOW; BRAIN CANCER; BRAIN CORTEX; BRAIN HEMORRHAGE; BRAIN MALFORMATION; BRAIN METABOLISM; BRAIN TUMOR; CANCER GRADING; CANCER RADIOTHERAPY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CONVALESCENCE; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EARLY DIAGNOSIS; EPILEPTIC FOCUS; FOCAL EPILEPSY; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; HEMISPHERECTOMY; HUMAN; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SHY DRAGER SYNDROME; SIDE EFFECT; STROKE; TEMPORAL LOBE EPILEPSY; TREATMENT OUTCOME; TUMOR RECURRENCE;

EID: 3543071107     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mibio.2004.05.002     Document Type: Article

References (492)

1. Herholz K. FDG-PET and differential diagnosis of dementia Alzheimer Dis. Assoc. Disord. 9 1995 6-16
2. Herholz K. Salmon E. Perani D. et al. Discrimination between Alzheimer Dementia and controls by automated analysis of multicenter FDG-PET Neuroimage 17 2002 302-316
3. Zündorf G. Kerrouche N. Herholz K. Baron J.C. An efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging Hum. Brain Mapp. 18 2003 13-211
4. Minoshima S. Giordani B. Berent S. et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease Ann. Neurol. 42 1997 85-94
5. Gusnard D.A. Raichle M.E. Raichle M.E. Searching for a baseline: functional imaging and the resting human brain Nat. Rev. Neurosci. 2 2001 685-694
6. Burdette J.H. Minoshima S. Vander Borght T. Tran D.D. Kuhl D.E. Alzheimer disease: improved visual interpretation of PET images by using threedimensional stereotaxic surface projections Radiology. 198 1996 837-843
7. Signorini M. Paulesu E. Friston K. et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG-PET: a clinical validation of statistical parametric mapping Neuroimage 9 1999 63-80
8. Ishii K. Willoch F. Minoshima S. et al. Statistical brain mapping of 18F-FDG-PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains J. Nucl. Med. 42 2001 548-557
9. Salmon E. Collette F. Degueldre C. Lemaire C. Franck G. Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease Hum. Brain Mapp. 10 2000 39-48
10. Silverman D.H. Small G.W. Chang C.Y. et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome JAMA 286 2001 2120-2127
11. Small G.W. Ercoli L.M. Silverman D.H. et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease Proc. Natl. Acad. Sci. USA. 97 2000 6037-6042
12. Reiman E.M. Caselli R.J. Chen K. et al. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease Proc. Natl. Acad. Sci. USA. 98 2001 3334-3339
13. Reiman E.M. Caselli R.J. Yun L.S. et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E N. Engl. J. Med. 334 1996 752-758
14. Small G.W. Mazziotta J.C. Collins M.T. et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease JAMA 273 1995 942-947
15. de Leon M.J. Convit A. Wolf O.T. et al. Prediction of cognitive decline in normal elderly subjects with 2-F-18-fluoro-2-deoxy-D-glucose positron-emission tomography (FDG-PET) Proc. Natl. Acad. Sci. USA 98 2001 10966-10971
16. Herholz K. Nordberg A. Salmon E. et al. Metabolic impairment of association cortex predicts progression in Alzheimer's disease: a prospective multicenter positron emission tomography (PET) study Eur. J. Neurol. 5 1998 S24
17. Berent S. Giordani B. Foster N. et al. Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease J. Psychiatr. Res. 33 1999 7-16
18. Arnaiz E. Jelic V. Almkvist O. et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment Neuroreport 12 2001 851-855
19. Drzezga A. Lautenschlager N. Siebner H. et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study Eur. J. Nucl. Med. Mol. Imaging. 30 2003 1104-1113
20. Chetelat G. Desgranges B. de la Sayette V. et al. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 60 2003 1374-1377
21. Kuhl D.E. Metter E.J. Riege W.H. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method Ann. Neurol. 15 1984 419-424
22. Schapiro M.B. Pietrini P. Grady C.L. et al. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease J. Neurol. Neurosurg. Psychiatry. 56 1993 859-864
23. Eidelberg D. Moeller J.R. Ishikawa T. et al. Assessment of disease severity in parkinsonism with fluorine-18- fluorodeoxyglucose and PET J. Nucl. Med. 36 1995 378-383
24. Hilker R. Voges J. Thiel A. et al. Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDG-PET J. Neural Transm. 10 2002 1257-1264
25. Grady C.L. Haxby J.V. Horwitz B. Berg G. Rapoport S.I. Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type Neuropsychologia. 25 1987 807-816
26. Mielke R. Herholz K. Grond M. Kessler J. Heiss W.D. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type Neurobiol. Aging. 13 1992 93-98
27. Herholz K. Schopphoff H. Schmidt M. et al. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer disease J. Nucl. Med. 43 2002 21-26
28. Mielke R. Pietrzyk U. Jacobs A. et al. HMPAO SPET and FDG-PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern Eur. J. Nucl. Med. 21 1994 1052-1060
29. Messa C. Perani D. Lucignani G. et al. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG-PET J. Nucl. Med. 35 1994 210-216
30. Okamura N. Arai H. Maruyama M. et al. Combined analysis of CSF tau levels and [(123)I]Iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer's disease Am. J. Psychiatry. 159 2002 474-476
31. Huang C. Wahlund L.O. Svensson L. Winblad B. Julin P. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment BMC Neurol. 2 2002 9
32. Perry E.K. Haroutunian V. Davis K.L. et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease Neuroreport. 5 1994 747-749
33. Candy J.M. Perry R.H. Perry E.K. et al. Pathological changes in the nucleus basalis of Meynert in Alzheimer's and Parkinson's disease J. Neurol. Sci. 59 1983 277-289
34. Mann D.M. Yates P.O. Marcyniuk B. The nucleus basalis of Meynert in multi-infarct (vascular) dementia Acta Neuropathol. (Berl.) 71 1986 332-337
35. Irie T. Fukushi K. Namba H. et al. Brain acetylcholinesterase activity-validation of a PET tracer in a rat model of Alzheimers disease J. Nucl. Med. 37 1996 649-655
36. Kilbourn M.R. Snyder S.E. Sherman P.S. Kuhl D.E. In vivo studies of acetylcholinesterase activity using a labeled substrate, n-[C-11]methylpiperdin-4-yl propionate ([C-11]PMP) Synapse 22 1996 123-131
37. Shinotoh H. Namba H. Fukushi K. et al. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study Ann. Neurol. 48 2000 194-200
38. Herholz K. Bauer B. Wienhard K. et al. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism J. Neural. Transm. 12 2000 1457-1468
39. Kuhl D.E. Koeppe R.A. Minoshima S. et al. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease Neurology 52 1999 691-699
40. Herholz K. Weisenbach S. Zündorf G. et al. In-vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease Neuroimage 21 2004 136-143
41. Volkow N.D. Ding Y.S. Fowler J.S. Gatley S.J. Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia Biol. Psychiatry. 49 2001 211-220
42. Bacskai B.J. Klunk W.E. Mathis C.A. Hyman B.T. Imaging amyloid-beta deposits in vivo J. Cereb. Blood Flow Metab. 22 2002 1035-1041
43. Shoghi-Jadid K. Small G.W. Agdeppa E.D. et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease Am. J. Geriatr. Psychiatry. 10 2002 24-35
44. Klunk W. Debnath M. Holt D. et al. Potential amyloid-imaging agents: binding ratios to homogenates of post-mortem AD and control brain Neurobiol. Aging. 23 2002 1149
45. Agdeppa E.D. Kepe V. Liu J. et al. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease J. Neurosci. 21 2001 RC189
46. Agdeppa E.D. Kepe V. Petri A. et al. In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-{6-[(2-[18F] fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile Neuroscience. 117 2003 723-730
47. Mathis C.A. Bacskai B.J. Kajdasz S.T. et al. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain Bioorg. Med. Chem. Lett. 12 2002 295-298
48. Kung M.P. Skovronsky D.M. Hou C. et al. Detection of amyloid plaques by radioligands for A beta 40 and A beta 42-potential imaging agents in Alzheimer's patients J. Mol. Neurosci. 20 2003 15-23
49. Zhuang Z.P. Kung M.P. Wilson A. et al. Structure-activity relationship of imidazo[1, 2-alpha]pyridines as ligands for detecting beta-amyloid plaques in the brain J. Med. Chem. 46 2003 237-243
50. Kung M.P. Hou C. Zhuang Z.P. et al. IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques Brain Res. 956 2002 202-210
51. Klunk W.E. Wang Y. Huang G.F. et al. The binding of 2-(4′-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component J. Neurosci. 23 2003 2086-2092
52. Mathis C.A. Wang Y.M. Holt D.P. et al. Synthesis and evaluation of C-11-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents J. Med. Chem. 46 2003 2740-2754
53. Bacskai B.J. Hickey G.A. Skoch J. et al. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-{beta} ligand in transgenic mice Proc. Natl. Acad. Sci. USA. 2003 epub: 2034101100
54. Engler H. Blomqvist G. Bergstrom M. et al. First human study with a benzothiazole amyloid-imaging agent in Alzheimer's disease and control subjects Neurobiol. Aging 23 2002 1568
55. Ono M. Wilson A. Nobrega J. et al. 11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease Nucl. Med. Biol. 30 2003 565-571
56. Perry R.H. Irving D. Blessed G. Fairbairn A. Perry E.K. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly J. Neurol. Sci. 95 1990 119-139
57. Verghese J. Crystal H.A. Dickson D.W. Lipton R.B. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies Neurology 53 1999 1974-1982
58. Ishii K. Imamura T. Sasaki M. et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease Neurology 51 1998 125-130
59. Higuchi M. Tashiro M. Arai H. et al. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies Exp. Neurol. 162 2000 247-256
60. Minoshima S. Foster N.L. Sima A.A. et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation Ann. Neurol. 50 2001 358-365
61. Hu X.S. Okamura N. Arai H. et al. 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with lewy bodies Neurology 55 2000 1575-1577
62. Hisanaga K. Suzuki H. Tanji H. et al. Fluoro-DOPA and FDG positron emission tomography in a case of pathologically verified pure diffuse Lewy body disease J. Neurol. 248 2001 905-906
63. Tyrrell P.J. Sawle G.V. Ibanez V. et al. Clinical and positron emission tomographic studies in the "extrapyramidal syndrome" of dementia of the Alzheimer type Arch. Neurol. 47 1990 1318-1323
64. Neary D. Snowden J.S. Gustafson L. et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Neurology 51 1998 1546-1554
65. Kertesz A. Munoz D. Pick's disease, frontotemporal dementia, and Pick complex: emerging concepts Arch. Neurol. 55 1998 302-304
66. Friedland R.P. Koss E. Lerner A. et al. Functional imaging, the frontal lobes, and dementia Dementia 4 1993 192-203
67. Kamo H. McGeer P.L. Harrop R. et al. Positron emission tomography and histopathology in Pick's disease Neurology 37 1987 439-445
68. Salmon E. Garraux G. Delbeuck X. et al. Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia Neuroimage 20 2003 435-440
69. Hosaka K. Ishii K. Sakamoto S. et al. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration J. Neurol. Sci. 199 2002 67-71
70. Feany M.B. Mattiace L.A. Dickson D.W. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration J. Neuropathol. Exp. Neurol. 55 1996 53-67
71. Karbe H. Grond M. Huber M. et al. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography J. Neurol. 239 1992 98-102
72. Soong B. Liu R. Wu L. Lu Y. Lee H. Metabolic characterization of spinocerebellar ataxia type 6 Arch. Neurol. 58 2001 300-304
73. Volkow N.D. Hitzemann R. Wang G.J. et al. Long-term frontal brain metabolic changes in cocaine abusers Synapse 11 1992 184-190
74. Erkinjuntti T. Ostbye T. Steenhuis R. Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia N. Engl. J. Med. 337 1997 1667-1674
75. Chui H.C. Mack W. Jackson J.E. et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability Arch. Neurol. 57 2000 191-196
76. Mielke R. Herholz K. Grond M. Kessler J. Heiss W.D. Severity of vascular dementia is related to volume of metabolically impaired tissue Arch. Neurol. 49 1992 909-913
77. Sultzer D.L. Mahler M.E. Cummings J.L. et al. Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings Arch. Neurol. 52 1995 773-780
78. Ogawa T. Inugami A. Fujita H. et al. Serial positron emission tomography with fludeoxyglucose F 18 in Creutzfeldt-Jakob disease AJNR Am. J. Neuroradiol. 16 1995 978-981
79. Matochik J.A. Molchan S.E. Zametkin A.J. et al. Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease Acta Neurol. Scand. 91 1995 153-157
80. Goldman S. Laird A. Flament-Durand J. et al. Positron emission tomography and histopathology in Creutzfeldt- Jakob disease Neurology 43 1993 1828-1830
81. Holthoff V.A. Sandmann J. Pawlik G. Schröder R. Heiss W.D. Positron emission tomography in Creutzfeldt-Jakob disease Arch. Neurol. 47 1990 1035-1038
82. Engler H. Lundberg P.O. Ekbom K. et al. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease Eur. J. Nucl. Med. Mol. Imaging. 30 2003 85-95
83. Sawle G.V. Playford E.D. Burn D.J. Cunningham V.J. Brooks D.J. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data Arch. Neurol. 51 1994 237-243
84. Stoof J.C. Winogrodzka A. van Muiswinkel F.L. et al. Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy Eur. J. Pharmacol. 375 1999 75-86
85. Hughes A.J. Daniel S.E. Ben Shlomo Y. Lees A.J. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service Brain 125 2002 861-870
86. Nahmias C. Garnett E.S. Firnau G. Lang A. Striatal dopamine distribution in parkinsonian patients during life J. Neurol. Sci. 69 1985 223-230
87. Leenders K.L. Palmer A.J. Quinn N. et al. Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography J. Neurol. Neurosurg. Psychiatry. 49 1986 853-860
88. Damier P. Hirsch E.C. Agid Y. Graybiel A.M. The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease Brain 122 1999 1437-1448
89. Garnett E.S. Lang A.E. Chirakal R. Firnau G. Nahmias C. A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum Can. J. Neurol. Sci. 14 1987 444-447
90. Antonini A. Vontobel P. Psylla M. et al. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease Arch. Neurol. 52 1995 1183-1190
91. Pal P.K. Lee C.S. Samii A. et al. Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET Parkinsonism Relat. Disord. 7 2001 305-309
92. Brooks D.J. Playford E.D. Ibanez V. et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study [see comments] Neurology. 42 1992 1554-1560
93. Ghaemi M. Raethjen J. Hilker R. et al. Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study Mov. Disord. 17 2002 782-788
94. Antonini A. Moresco R.M. Gobbo C. et al. The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT Neurol. Sci. 22 2001 47-48
95. Burn D.J. Sawle G.V. Brooks D.J. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data J. Neurol. Neurosurg. Psychiatry. 57 1994 278-284
96. Antonini A. Kazumata K. Feigin A. et al. Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET Mov. Disord. 13 1998 268-274
97. Otsuka M. Kuwabara Y. Ichiya Y. et al. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG Ann. Nucl. Med. 11 1997 251-257
98. Ghaemi M. Hilker R. Rudolf J. Sobesky J. Heiss W.D. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging J. Neurol. Neurosurg. Psychiatry. 73 2002 517-523
99. Boecker H. Weindl A. Leenders K. et al. Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa Acta Neurol. Scand. 93 1996 387-392
100. Karbe H. Holthoff V. Huber M. et al. Positron emission tomography in degenerative disorders of the dopaminergic system J. Neural Transm. 4 1992 121-130
101. Kume A. Shiratori M. Takahashi A. et al. Hemi-parkinsonism in multiple system atrophy: a PET and MRI study J. Neurol. Sci. 110 1992 37-45
102. Eidelberg D. Moeller J.R. Ishikawa T. et al. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography Neurology 45 1995 1995-2004
103. Martin W.R. Palmer M.R. Patlak C.S. Calne D.B. Nigrostriatal function in humans studied with positron emission tomography Ann. Neurol. 26 1989 535-542
104. Sawle G.V. Colebatch J.G. Shah A. et al. Striatal function in normal aging: implications for Parkinson's disease Ann. Neurol. 28 1990 799-804
105. Dhawan V. Ishikawa T. Patlak C. et al. Combined FDOPA and 3OMFD PET studies in Parkinson's disease [see comments] J. Nucl. Med. 37 1996 209-216
106. Vingerhoets F.J. Schulzer M. Ruth T.J. Holden J.E. Snow B.J. Reproducibility and discriminating ability of fluorine-18-6- fluoro-L-Dopa PET in Parkinson's disease J. Nucl. Med. 37 1996 421-426
107. Eidelberg D. Moeller J.R. Dhawan V. et al. The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies Mov. Disord. 5 1990 203-213
108. Rougemont D. Baron J.C. Collard P. et al. Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry. 47 1984 824-830
109. Antonini A. Moeller J.R. Nakamura T. et al. The metabolic anatomy of tremor in Parkinson's disease Neurology 51 1998 803-810
110. Arahata Y. Hirayama M. Ieda T. et al. Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure J. Neurol. Sci. 163 1999 119-126
111. Berding G. Odin P. Brooks D.J. et al. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET Mov. Disord. 16 2001 1014-1022
112. Hu M.T. Taylor-Robinson S.D. Chaudhuri K.R. et al. Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study Brain 123 2000 340-352
113. Metter E.J. Kuhl D.E. Riege W.H. Brain glucose metabolism in Parkinson's disease Adv. Neurol. 53 1990 135-139
114. Wu J.C. Iacono R. Ayman M. et al. Correlation of intellectual impairment in Parkinson's disease with FDG-PET scan [In Process Citation] Neuroreport. 11 2000 2139-2144
115. Bohnen N.I. Minoshima S. Giordani B. Frey K.A. Kuhl D.E. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia Neurology 52 1999 541-546
116. Peppard R.F. Martin W.R. Carr G.D. et al. Cerebral glucose metabolism in Parkinson's disease with and without dementia Arch. Neurol. 49 1992 1262-1268
117. Holthoff-Detto V.A. Kessler J. Herholz K. et al. Functional effects of striatal dysfunction in Parkinson disease Arch Neurol. 54 1997 145-150
118. Turjanski N. Brooks D.J. PET and the investigation of dementia in the parkinsonian patient J. Neural Transm. Suppl. 51 1997 37-48
119. Mentis M.J. McIntosh A.R. Perrine K. et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease Am. J. Psychiatry. 159 2002 746-754
120. D'Antona R. Baron J.C. Samson Y. et al. Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy Brain 108 1985 785-799
121. Foster N.L. Gilman S. Berent S. et al. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography Ann. Neurol. 24 1988 399-406
122. Goffinet A.M. De Volder A.G. Gillain C. et al. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy Ann. Neurol. 25 1989 131-139
123. Blin J. Baron J.C. Dubois B. et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations Arch. Neurol. 47 1990 747-752
124. Yamauchi H. Fukuyama H. Nagahama Y. et al. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy Ann. Neurol. 41 1997 606-614
125. Garraux G. Salmon E. Peigneux P. et al. Voxel-based distribution of metabolic impairment in corticobasal degeneration Mov. Disord. 15 2000 894-904
126. Salmon E. Vanderlinden M. Franck G. Anterior cingulate and motor network metabolic impairment in progressive supranuclear palsy Neuroimage 5 1997 173-178
127. Garraux G. Salmon E. Degueldre C. et al. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia Neuroimage 10 1999 149-162
128. Bhatt M.H. Snow B.J. Martin W.R. Peppard R. Calne D.B. Positron emission tomography in progressive supranuclear palsy Arch. Neurol. 48 1991 389-391
129. Leenders K.L. Frackowiak R.S. Lees A.J. Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography Brain 111 1988 615-630
130. Cordes M. Snow B.J. Morrison S. et al. Parametric imaging of the rate constant Ki using [18Fluoro]-L- dopa positron emission tomography in progressive supranuclear palsy Neuroradiology 35 1993 404-409
131. Brooks D.J. Ibanez V. Sawle G.V. et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy Ann. Neurol. 28 1990 547-555
132. Ilgin N. Zubieta J. Reich S.G. et al. PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease Neurology 52 1999 1221-1226
133. Hornykiewicz O. Shannak K. Brain monoamines in progressive supranuclear palsy-comparison with idiopathic Parkinson's disease [Review] J. Neural Transm. Suppl. 42 1994 219-227
134. Baron J.C. Maziere B. Loc'h C. et al. Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy J. Cereb. Blood Flow Metab. 6 1986 131-136
135. Brooks D.J. Ibanez V. Sawle G.V. et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography Ann. Neurol. 31 1992 184-192
136. Burn D.J. Rinne J.O. Quinn N.P. et al. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, a [11C]diprenorphine PET study Brain 118 1995 951-958
137. Kuhl D.E. Metter E.J. Riege W.H. Markham C.H. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease Ann. Neurol. 15 Suppl 1984 S119-S125
138. Garnett E.S. Firnau G. Nahmias C. Carbotte R. Bartolucci G. Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease J. Neurol. Sci. 65 1984 231-237
139. Mazziotta J.C. Huntington's disease: studies with structural imaging techniques and positron emission tomography Semin. Neurol. 9 1989 360-369
140. Otsuka M. Ichiya Y. Kuwabara Y. et al. Cerebral glucose metabolism and striatal 18F-dopa uptake by PET in cases of chorea with or without dementia J. Neurol. Sci. 115 1993 153-157
141. Martin W.R. Clark C. Ammann W. et al. Cortical glucose metabolism in Huntington's disease Neurology 42 1992 223-229
142. Kuwert T. Lange H.W. Langen K.J. et al. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease Brain 113 Pt 5 1990 1405-1423
143. De Volder A. Bol A. Michel C. et al. Brain glucose utilization in childhood Huntington's disease studied with positron emission tomography (PET) Brain Dev. 10 1988 47-50
144. Hayden M.R. Martin W.R. Stoessl A.J. et al. Positron emission tomography in the early diagnosis of Huntington's disease Neurology 36 1986 888-894
145. Young A.B. Penney J.B. Starosta-Rubinstein S. et al. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline Ann. Neurol. 20 1986 296-303
146. Kuhl D.E. Phelps M.E. Markham C.H. et al. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan Ann. Neurol. 12 1982 425-434
147. Dierks T. Linden D.E. Hertel A. et al. Multimodal imaging of residual function and compensatory resource allocation in cortical atrophy: a case study of parietal lobe function in a patient with Huntington's disease Psychiatr. Res. 90 1999 67-75
148. Matthews P.M. Evans A.C. Andermann F. Hakim A.M. Regional cerebral glucose metabolism differs in adult and rigid juvenile forms of Huntington disease. Pediatr Neurol. 5 1989 353-356
149. Grafton S.T. Mazziotta J.C. Pahl J.J. et al. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease Arch. Neurol. 49 1992 1161-1167
150. Kuwert T. Noth J. Scholz D. et al. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease Mov. Disord. 8 1993 98-106
151. Grafton S.T. Mazziotta J.C. Pahl J.J. et al. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease Ann. Neurol. 28 1990 614-621
152. Hayden M.R. Hewitt J. Stoessl A.J. et al. The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease Neurology 37 1987 1441-1447
153. Mazziotta J.C. Phelps M.E. Pahl J.J. et al. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease N. Engl. J. Med. 316 1987 357-362
154. Young A.B. Penney J.B. Starosta-Rubinstein S. et al. Normal caudate glucose metabolism in persons at risk for Huntington's disease Arch. Neurol. 44 1987 254-257
155. Ginovart N. Lundin A. Farde L. et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease Brain 120 1997 503-514
156. Turjanski N. Weeks R. Dolan R. Harding A.E. Brooks D.J. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study Brain 118 1995 689-696
157. Sedvall G. Karlsson P. Lundin A. et al. Dopamine D1 receptor number-a sensitive PET marker for early brain degeneration in Huntington's disease Eur. Arch. Psychiatr. Clin. Neurosci. 243 1994 249-255
158. Pavese N. Andrews T.C. Brooks D.J. et al. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study Brain 126 2003 1127
159. Andrews T.C. Weeks R.A. Turjanski N. et al. Huntington's disease progression: PET and clinical observations Brain 122 1999 2353-2363
160. Leenders K.L. Frackowiak R.S. Quinn N. Marsden C.D. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography Mov. Disord. 1 1986 69-77
161. Antonini A. Leenders K.L. Eidelberg D. [11C]raclopride-PET studies of the Huntington's disease rate of progression: relevance of the trinucleotide repeat length Ann. Neurol. 43 1998 253-255
162. Weeks R.A. Piccini P. Harding A.E. Brooks D.J. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease Ann. Neurol. 40 1996 49-54
163. Berent S. Giordani B. Lehtinen S. et al. Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function Ann. Neurol. 23 1988 541-546
164. Brandt J. Folstein S.E. Wong D.F. et al. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates J. Neuropsychiatr. Clin. Neurosci. 2 1990 20-27
165. Goldman S. Amrom D. Szliwowski H.B. et al. Reversible striatal hypermetabolism in a case of Sydenham's chorea Mov. Disord. 8 1993 355-358
166. Sunden-Cullberg J. Tedroff J. Aquilonius S.M. Reversible chorea in primary antiphospholipid syndrome Mov. Disord. 13 1998 147-149
167. Guttman M. Lang A.E. Garnett E.S. et al. Regional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea Mov. Disord. 2 1987 201-210
168. Hosokawa S. Ichiya Y. Kuwabara Y. et al. Positron emission tomography in cases of chorea with different underlying diseases J. Neurol. Neurosurg. Psychiatry 50 1987 1284-1287
169. Tanaka M. Hirai S. Kondo S. et al. Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis: a combined PET and MRI study Mov. Disord. 13 1998 100-107
170. Kuwert T. Lange H.W. Langen K.J. et al. Normal striatal glucose consumption in two patients with benign hereditary chorea as measured by positron emission tomography J. Neurol. 237 1990 80-84
171. Suchowersky O. Hayden M.R. Martin W.R. et al. Cerebral metabolism of glucose in benign hereditary chorea Mov. Disord. 1 1986 33-44
172. Gilman S. Sima A.A.F. Junck L. et al. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions Ann. Neurol. 39 1996 241-255
173. Gilman S. Heumann M. Junck L. Neurodegenerative disorders of the cerebellum Toga A.W. Mazziotta J.C. Frackowiak R.S.J. (Eds.). Brain mapping: the disorders 2000 417 455 Academic Press San Diego
174. Soong B.W. Liu R.S. Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease J. Neurol. Neurosurg. Psychiatry 64 1998 499-504
175. Taniwaki T. Sakai T. Kobayashi T. et al. Positron emission tomography (PET) in Machado-Joseph disease J. Neurol. Sci. 145 1997 63-67
176. Furtado S. Farrer M. Tsuboi Y. et al. SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings Neurology 59 2002 1625-1627
177. Anderson N.E. Posner J.B. Sidtis J.J. et al. The metabolic anatomy of paraneoplastic cerebellar degeneration Ann. Neurol. 23 1988 533-540
178. Gilman S. Adams K. Koeppe R.A. et al. Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography Ann. Neurol. 28 1990 775-785
179. Alavi J.B. Alavi A. Chawluk J. et al. Positron emission tomography in patients with glioma. A predictor of prognosis Cancer 62 1988 1074-1078
180. Di Chiro G. DeLaPaz R.L. Brooks R.A. et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography Neurology 32 1982 1323-1329
181. Barker F.G. Chang S.M. Valk P.E. Pounds T.R. Prados M.D. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma Cancer 79 1997 115-126
182. Patronas N.J. Di Chiro G. Kufta C. et al. Prediction of survival in glioma patients by means of positron emission tomography J. Neurosurg. 62 1985 816-822
183. Delbeke D. Meyerowitz C. Lapidus R.L. et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET Radiology 195 1995 47-52
184. Okada J. Yoshikawa K. Imazeki K. et al. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis J. Nucl. Med. 32 1991 686-691
185. Basso U. Brandes A.A. Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma Eur. J. Cancer. 38 2002 1298-1312
186. Hoffman J.M. Waskin H.A. Schifter T. et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS J. Nucl. Med. 34 1993 567-575
187. Rohren E.M. Provenzale J.M. Barboriak D.P. Coleman R.E. Screening for cerebral metastases with FDG-PET in patients undergoing whole-body staging of non-central nervous system malignancy Radiology 226 2003 181-187
188. Roelcke U. Radu E.W. Hausmann O. et al. Tracer transport and metabolism in a patient with juvenile pilocytic astrocytoma. A PET study J. Neurooncol. 36 1998 279-283
189. Fulham M.J. Melisi J.W. Nishimiya J. Dwyer A.J. Di Chiro G. Neuroimaging of juvenile pilocytic astrocytomas: an enigma [see comments] Radiology 189 1993 221-225
190. Di Chiro G. Hatazawa J. Katz D.A. Rizzoli H.V. De Michele D.J. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study Radiology 164 1987 521-526
191. Borbely K. Fulham M.J. Brooks R.A. Di Chiro G. PET-fluorodeoxyglucose of cranial and spinal neuromas J. Nucl. Med. 33 1992 1931-1934
192. De Souza B. Brunetti A. Fulham M.J. et al. Pituitary microadenomas: a PET study Radiology 177 1990 39-44
193. Komori T. Martin W.H. Graber A.L. Delbeke D. Serendipitous detection of Cushing's disease by FDG positron emission tomography and a review of the literature Clin. Nucl. Med. 27 2002 176-178
194. Daemen B.J. Zwertbroek R. Elsinga P.H. et al. PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment Eur. J. Nucl. Med. 18 1991 453-460
195. Wilkinson M.D. Fulham M.J. Besser M. Neuroimaging findings in a suprasellar granular cell tumor J. Comput. Assist. Tomogr. 27 2003 26-29
196. Kaschten B. Stevenaert A. Sadzot B. et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine J. Nucl. Med. 39 1998 778-785
197. Chung J.K. Kim Y.K. Kim S.K. et al. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG-PET Eur. J. Nucl. Med. Mol. Imaging. 29 2002 176-182
198. Ogawa T. Inugami A. Hatazawa J. et al. Clinical positron emission tomography for brain tumors-comparison of fludeoxyglucose F 18 and l-methyl-C-11-methionine AJNR Am. J. Neuroradiol. 17 1996 345-353
199. Ericson K. Lilja A. Bergstrom M. et al. Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors J. Comput. Assist. Tomogr. 9 1985 683-689
200. Ogawa T. Shishido F. Kanno I. et al. Cerebral glioma: evaluation with methionine PET Radiology 186 1993 45-53
201. Kracht L.W. Friese M. Herholz K. et al. Methyl-[(11)C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma Eur. J. Nucl. Med. Mol. Imaging. 30 2003 868-873
202. Bustany P. Chatel M. Derlon J.M. et al. Brain tumor protein synthesis and histological grades: a study by positron emission tomography (PET) with C11-L-Methionine J. Neurooncol. 3 1986 397-404
203. Sasaki M. Kuwabara Y. Yoshida T. et al. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours Eur. J. Nucl. Med. 25 1998 1261-1269
204. Herholz K. Hölzer T. Bauer B. et al. 11C-Methionine PET for differential diagnosis of low-grade gliomas Neurology 50 1998 1316-1322
205. De Witte O. Goldberg I. Wikler D. et al. Positron emission tomography with injection of methionine as a prognostic factor in glioma J. Neurosurg. 95 2001 746-750
206. Levivier M. Goldman S. Pirotte B. et al. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose J. Neurosurg. 82 1995 445-452
207. Goldman S. Levivier M. Pirotte B. et al. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy J. Nucl. Med. 38 1997 1459-1462
208. Pirotte B. Goldman S. Salzberg S. et al. Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children: experience in 9 cases Pediatr. Neurosurg. 38 2003 146-155
209. Derlon J.M. Petit-Taboue M.C. Chapon F. et al. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine Neurosurgery 40 1997 276-288
210. Ogawa T. Kanno I. Hatazawa J. et al. Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain Radiographics 14 1994 101-110
211. Sawataishi J. Mineura K. Sasajima T. et al. Effects of radiotherapy determined by 11C-methyl-L-methionine positron emission tomography in patients with primary cerebral malignant lymphoma Neuroradiology 34 1992 517-519
212. Padma M.V. Jacobs M. Kraus G. et al. 11C-methionine PET imaging of leptomeningeal metastases from primary breast cancer - a case report J. Neurooncol. 55 2001 39-44
213. Nyberg G. Bergstrom M. Enblad P. et al. PET-methionine of skull base neuromas and meningiomas Acta Otolaryngol. 117 1997 482-489
214. Nuutinen J. Sonninen P. Lehikoinen P. et al. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma Int. J. Radiat. Oncol. Biol. Phys. 48 2000 43-52
215. Utriainen M. Metsahonkala L. Salmi T.T. et al. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography Cancer 95 2002 1376-1386
216. Ribom D. Eriksson A. Hartman M. et al. Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas Cancer 92 2001 1541-1549
217. Braun V. Dempf S. Weller R. et al. Cranial neuronavigation with direct integration of (11)C methionine positron emission tomography (PET) data-results of a pilot study in 32 surgical cases Acta Neurochir. (Wien). 144 2002 777-782
218. Dethy S. Goldman S. Blecic S. et al. Carbon-11-methionine and fluorine-18-FDG-PET study in brain hematoma J. Nucl. Med. 35 1994 1162-1166
219. Tsuyuguchi N. Sunada I. Ohata K. et al. Evaluation or treatment effects in brain abscess with positron emission tomography: comparison of Fluorine-18-Fluorodeoxyglucose and Carbon-11-Methionine Ann. Nucl. Med. 17 2003 47-51
220. Dethy S. Manto M. Kentos A. et al. PET findings in a brain abscess associated with a silent atrial septal defect Clin. Neurol. Neurosurg. 97 1995 349-353
221. Jacobs A. Amino acid uptake in ischemically compromised brain tissue Stroke 26 1995 1859-1866
222. Bergstrom M. Muhr C. Lundberg P.O. et al. Amino acid distribution and metabolism in pituitary adenomas using positron emission tomography with D-[11C] methionine and L-[11C]methionine J. Comput. Assist. Tomogr. 11 1987 384-389
223. Bergstrom M. Muhr C. Ericson K. et al. The normal pituitary examined with positron emission tomography and (methyl-11C)-L-methionine and (methyl-11C)-D-methionine Neuroradiology 29 1987 221-225
224. Mankoff D.A. Shields A.F. Link J.M. et al. Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies J. Nucl. Med. 40 1999 614-624
225. Shields A.F. Grierson J.R. Dohmen B.M. et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography Nat. Med. 4 1998 1334-1336
226. Jacobs A.H. Dittmar C. Garlip G. et al. Identification of DNA and amino acid metabolism in human gliomas by PET J. Cereb. Blood Flow Metab. 23 Suppl. 1 2003 376
227. Vesselle H. Grierson J. Muzi M. et al. In vivo validation of 3′deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors Clin. Cancer Res. 8 2002 3315-3323
228. Hölzer T. Herholz K. Jeske J. Heiss W.D. FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma J. Comput. Assist. Tomogr. 17 1993 681-687
229. Holthoff V.A. Herholz K. Berthold F. et al. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment Cancer 72 1993 1394-1403
230. Di Chiro G. Positron emission tomography using [F-18]-fluorodeoxyglucose in brain tumors - a powerful diagnostic and prognostic tool Invest. Radiol. 22 1987 360-371
231. Francavilla T.L. Miletich R.S. Di Chiro G. et al. Positron emission tomography in the detection of malignant degeneration of low-grade gliomas Neurosurgery 24 1989 1-5
232. Forsyth P.A. Kelly P.J. Cascino T.L. et al. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful? J. Neurosurg. 82 1995 436-444
233. Bryan R.N. What's your favorite PET story? AJNR Am. J. Neuroradiol. 19 1998 590
234. Schiffer D. Giordana M.T. Soffietti R. Sciolla R. Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy Acta Neuropathol. (Berl.) 58 1982 291-299
235. Patronas N.J. Di Chiro G. Brooks R.A. et al. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain Radiology 144 1982 885-889
236. Di Chiro G. Oldfield E. Wright D.C. et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies AJR Am. J. Roentgenol. 150 1988 189-197
237. Doyle W.K. Budinger T.F. Valk P.E. Levin V.A. Gutin P.H. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography J. Comput. Assist. Tomogr. 11 1987 563-570
238. Levivier M. Becerra A. De Witte O. Brotchi J. Goldman S. Radiation necrosis or recurrence J. Neurosurg. 84 1996 148-149
239. Kracht L.W. Miletic H. Busch S. et al. Exact local comparison of [11C]-L-methionine uptake and histopathologic findings in 105 specimen from serial stereotactic biopsies Eur. J. Nucl. Med. 30 Suppl. 2 2003 190
240. Tsuyuguchi N. Sunada I. Iwai Y. et al. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J. Neurosurg. 98 2003 1056-1064
241. Ogawa T. Kanno I. Shishido F. et al. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl- 11C-methionine for diagnosis of recurrent brain tumor and radiation injury Acta Radiol. 32 1991 197-202
242. Reinhardt M.J. Kubota K. Yamada S. Iwata R. Yaegashi H. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine J. Nucl. Med. 38 1997 280-287
243. Thiel A. Pietrzyk U. Sturm V. et al. Enhanced accuracy in differentiated diagnosis of radiation necrosis by PET-MRI coregistration: case report Neurosurgery 46 2000 232-234
244. Tralins K.S. Douglas J.G. Stelzer K.J. et al. Volumetric analysis of 18F-FDG-PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation J. Nucl. Med. 43 2002 1667-1673
245. Takeda N. Diksic M. Yamamoto Y.L. The sequential changes in DNA synthesis, glucose utilization, protein synthesis, and peripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy Cancer 77 1996 1167-1179
246. Brock C.S. Young H. O'Reilly S.M. et al. Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas Br. J. Cancer. 82 2000 608-615
247. Yamamoto T. Nishizawa S. Maruyama I. et al. Acute effects of stereotactic radiosurgery on the kinetics of glucose metabolism in metastatic brain tumors: FDG-PET study Ann. Nucl. Med. 15 2001 103-109
248. De Witte O. Hildebrand J. Luxen A. Goldman S. Acute effect of carmustine on glucose metabolism in brain and glioblastoma Cancer 74 1994 2836-2842
249. Rozental J.M. Levine R.L. Nickles R.J. Dobkin J.A. Glucose uptake by gliomas after treatment. A positron emission tomographic study Arch. Neurol. 46 1989 1302-1307
250. Daemen B.J. Elsinga P.H. Paans A.M. et al. Radiation-induced inhibition of tumor growth as monitored by PET using L-[1-11C]tyrosine and fluorine-18-fluorodeoxyglucose J. Nucl. Med. 33 1992 373-379
251. Würker M. Herholz K. Voges J. et al. Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy Eur. J. Nucl. Med. 23 1996 583-586
252. Herholz K. Kracht L. Heiss W.-D. Monitoring of the effect of chemotherapy in a mixed glioma by C-11-methionine PET J. Neuroimag. 13 2003 269-271
253. Ribom D. Engler H. Blomquist E. Smits A. Potential significance of (11) C-methionine PET as a marker for the radiosensitivity of low-grade gliomas Eur. J. Nucl. Med. 29 2002 632-640
254. Ojemann J.G. Miller J.W. Silbergeld D.L. Preserved function in brain invaded by tumor Neurosurgery 39 1996 253-258
255. Krings T. Schreckenberger M. Rohde V. et al. Metabolic and electrophysiological validation of functional MRI J. Neurol. Neurosurg. Psychiatry. 71 2001 762-771
256. Kaplan A.M. Bandy D.J. Manwaring K.H. et al. Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors J. Neurosurg. 91 1999 797-803
257. Herholz K. Reulen H.J. von Stockhausen H.M. et al. Preoperative activation and intraoperative stimulation of language-related areas in glioma patients Neurosurgery 41 1997 1253-1262
258. Vinas F.C. Zamorano L. Mueller R.A. et al. [15O]-water PET and intraoperative brain mapping: a comparison in the localization of eloquent cortex Neurol. Res. 19 1997 601-608
259. Chang J.Y. Duara R. Barker W. Apicella A. Finn R. Two behavioral states studied in a single PET/FDG procedure: theory, method, and preliminary results J. Nucl. Med. 28 1987 852-860
260. Steinmetz H. Huang Y. Seitz R.J. et al. Individual integration of positron emission tomography and high- resolution magnetic resonance imaging J. Cereb. Blood Flow Metab. 12 1992 919-926
261. Pietrzyk U. Herholz K. Fink G. et al. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies J. Nucl. Med. 35 1994 2011-2018
262. Pietrzyk U. Herholz K. Heiss W.D. Three-dimensional alignment of functional and morphological tomograms J. Comput. Assist. Tomogr. 14 1990 51-59
263. Schreckenberger M. Spetzger U. Sabri O. et al. Preoperative PET activation for assessment of motor cortex area in precentral chondroma Surg. Neurol. 52 1999 24-29
264. Ojemann J.G. Neil J.M. MacLeod A.M.et al. Increased functional vascular response in the region of a glioma J. Cereb. Blood Flow Metab. 18 1998 148-153
265. Herholz K. Thiel A. Kracht L. Heiss W.-D. Two instances of excessive blood flow increase in brain tumors during functional brain activation Neuroimage. 9 Suppl. 1999 S569
266. Thiel A. Herholz K. Koyuncu A. et al. Plasticity of language networks in patients with brain tumors. A positron emission tomography activation study Ann. Neurol. 50 2001 620-629
267. Seitz R.J. Huang Y. Knorr U. et al. Large-scale plasticity of the human motor cortex Neuroreport. 6 1995 742-744
268. Müller R.A. Rothermel R.D. Behen M.E. et al. Plasticity of motor organization in children and adults Neuroreport 8 1997 3103-3108
269. Knorr U. Weder B. Kleinschmidt A. et al. Identification of task-specific rCBF changes in individual subjects: validation and application for PET J. Comput. Assist. Tomogr. 17 1993 517-528
270. Walter H. Kristeva R. Knorr U. et al. Individual somatotopy of primary sensorimotor cortex revealed by intermodal matching of MEG, PET, and MRI Brain Topogr. 5 1992 183-187
271. Seitz R.J. Schlaug G. Knorr U. et al. Neurophysiology of the human supplementary motor area. Positron emission tomography [Review] Adv. Neurol. 70 1996 167-175
272. Müller R.A. Rothermel R.D. Behen M.E. et al. Developmental changes of cortical and cerebellar motor control: a clinical positron emission tomography study with children and adults [In Process Citation] J. Child Neurol. 13 1998 550-556
273. Wunderlich G. Knorr U. Herzog H. et al. Precentral glioma location determines the displacement of cortical hand representation Neurosurgery 42 1998 18-26
274. Thiel A. Herholz K. von Stockhausen H.M. et al. Localization of language-related cortex with O-15-water in patients with gliomas Neuroimage. 7 1998 284-295
275. Ojemann G. Ojemann J. Lettich E. Berger M. Cortical language localization in left, dominant hemisphere J. Neurosurg. 71 1989 316-326
276. Herholz K. Thiel A. Wienhard K. et al. Individual functional anatomy of verb generation Neuroimage. 3 1996 185-194
277. Xiong J. Rao S. Jerabek P. et al. Intersubject variability in cortical activations during a complex language task Neuroimage. 12 2000 326-339
278. Hunter K.E. Blaxton T.A. Bookheimer S.Y. et al. (15)O water positron emission tomography in language localization: a study comparing positron emission tomography visual and computerized region of interest analysis with the Wada test Ann. Neurol. 45 1999 662-665
279. Müller R.A. Rothermel R.D. Muzik O. et al. Determination of language dominance by 15O-water PET in children and adolescents: a comparison with the Wada test J. Epilepsy. 11 1998 152-161
280. Pardo J.V. Fox P.T. Preoperative assessment of the cerebral hemisphere dominance for language with CBF PET Hum. Brain Mapp. 1 1993 57-68
281. Bookheimer S.Y. Zeffiro T.A. Blaxton T. et al. A direct comparison of PET activation and electrocortical stimulation mapping for language localization Neurology 48 1997 1056-1065
282. Nariai T. Senda M. Ishii K. et al. Three-dimensional imaging of cortical structure, function and glioma for tumor resection J. Nucl. Med. 38 1997 1563-1568
283. Papathanassiou D. Etard O. Mellet E. et al. A common language network for comprehension and production: a contribution to the definition of language epicenters with PET [In Process Citation] Neuroimage. 11 2000 347-357
284. Karbe H. Herholz K. Weber-Luxenburger G. Ghaemi M. Heiss W.-D. Cerebral networks and functional brain asymmetry. Evidence from regional metabolic changes during word repetition Brain Lang. 63 1998 108-121
285. Buckner R.L. Corbetta M. Schatz J. Raichle M.E. Petersen S.E. Preserved speech abilities and compensation following prefrontal damage Proc. Natl. Acad. Sci. USA. 93 1996 1249-1253
286. Leblanc R. Meyer E. Bub D. Zatorre R.J. Evans A.C. Language localization with activation positron emission tomography scanning Neurosurgery 31 1992 369-373
287. Bookheimer S.Y. Zeffiro T.A. Blaxton T.A. Gaillard P.W. Theodore W.H. Activation of language cortex with automatic speech tasks Neurology 55 2000 1151-1157
288. Herholz K. Thiel A. Pietrzyk U. et al. Magnetic resonance imaging-guided language activation PET in patients: technical aspects and clinical results in: Carson R.E. Daube-Witherspoon M.E. Herscovitch P. (eds.), Quantitative functional brain imaging with positron emission tomography 1998 159-163 Academic Press San Diego, CA
289. Müller R.A. Behen M.E. Rothermel R.D. et al. Brain organization for language in children, adolescents, and adults with left hemisphere lesion: a PET study [In Process Citation] Prog. Neuropsychopharmacol. Biol. Psychiatry. 23 1999 657-668
290. Tierney M.C. Varga M. Hosey L. Grafman J. Braun A. PET evaluation of bilingual language compensation following early childhood brain damage Neuropsychologia. 39 2001 114-121
291. Müller R.A. Rothermel R.D. Behen M.E. et al. Language organization in patients with early and late left-hemisphere lesion: a PET study [In Process Citation] Neuropsychologia. 37 1999 545-557
292. Heiss W.D. Experimental evidence of ischemic thresholds and functional recovery [Review] Stroke 23 1992 1668-1672
293. Heiss W.D. Graf R. The ischemic penumbra Curr. Opin. Neurol. 7 1994 11-19
294. Lyden P.D. Grotta J.C. Levine S.R. et al. Intravenous thrombolysis for acute stroke [Review] Neurology 49 1997 14-20
295. Baron J.C. Delattre J.Y. Bories J. et al. Comparison study of CT and positron emission tomographic data in recent cerebral infarction AJNR Am. J. Neuroradiol. 4 1983 536-540
296. Powers W.J. Grubb R.L. Jr. Darriet D. Raichle M.E. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans J. Cereb. Blood Flow Metab. 5 1985 600-608
297. Marchal G. Beaudouin V. Rioux P. et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis Stroke 27 1996 599-606
298. Furlan M. Marchal G. Viader F. Derlon J.M. Baron J.C. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra Ann. Neurol. 40 1996 216-226
299. Heiss W.D. Graf R. Wienhard K. et al. Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats J. Cereb. Blood Flow Metab. 14 1994 892-902
300. Baron J.C. Bousser M.G. Rey A. et al. Reversal of focal "misery-perfusion syndrome" by extra- intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography Stroke 12 1981 454-459
301. Wise R.J. Bernardi S. Frackowiak R.S. Legg N.J. Jones T. Serial observations on the pathophysiology of acute stroke. The transition from ischaemia to infarction as reflected in regional oxygen extraction Brain 106 1983 197-222
302. Heiss W.D. Huber M. Fink G.R. et al. Progressive derangement of periinfarct viable tissue in ischemic stroke J. Cereb. Blood Flow Metab. 12 1992 193-203
303. Hakim A.M. Evans A.C. Berger L. et al. The effect of nimodipine on the evolution of human cerebral infarction studied by PET J. Cereb. Blood Flow Metab. 9 1989 523-534
304. Sette G. Baron J.C. Young A.R. et al. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon Stroke 24 1993 2046-2057
305. Heiss W.D. Graf R. Fujita T. et al. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats Stroke 28 1997 2045-2051
306. Heiss W.D. Grond M. Thiel A. et al. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke Stroke 29 1998 454-461
307. Heiss W.D. Kracht L.W. Thiel A. Grond M. Pawlik G. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia Brain 124 2001 20-29
308. Ackerman R.H. Correia J.A. Alpert N.M. et al. Positron imaging in ischemic stroke disease using compounds labeled with oxygen 15. Initial results of clinicophysiologic correlations Arch. Neurol. 38 1981 537-543
309. Hakim A.M. Pokrupa R.P. Villanueva J. et al. The effect of spontaneous reperfusion on metabolic function in early human cerebral infarcts Ann. Neurol. 21 1987 279-289
310. Marchal G. Young A.R. Baron J.C. Early postischemic hyperperfusion: pathophysiologic insights from positron emission tomography J. Cereb. Blood Flow Metab. 19 1999 467-482
311. Marchal G. Serrati C. Rioux P. et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome Lancet 341 1993 925-927
312. Fink G.R. Herholz K. Pietrzyk U. Huber M. Heiss W.D. Peri-infarct perfusion in human ischemia: its relation to tissue metabolism, morphology, and clinical outcome J. Stroke Cerebrovasc. Dis. 3 1993 123-131
313. Lassen N.A. The luxury perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain Lancet II 1966 1113-1115
314. Kuhl D.E. Phelps M.E. Kowell A.P. et al. Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3 Ann. Neurol. 8 1980 47-60
315. Kushner M. Reivich M. Fieschi C. et al. Metabolic and clinical correlates of acute ischemic infarction Neurology 37 1987 1103-1110
316. Baron J.C. Rougemont D. Soussaline F. et al. Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study J. Cereb. Blood Flow Metab. 4 1984 140-149
317. Wise R.J. Rhodes C.G. Gibbs J.M. et al. Disturbance of oxidative metabolism of glucose in recent human cerebral infarcts Ann. Neurol. 14 1983 627-637
318. Syrota A. Castaing M. Rougemont D. et al. Tissue acid-base balance and oxygen metabolism in human cerebral infarction studied with positron emission tomography Ann. Neurol. 14 1983 419-428
319. Syrota A. Samson Y. Boullais C. et al. Tomographic mapping of brain intracellular pH and extracellular water space in stroke patients J. Cereb. Blood Flow Metab. 5 1985 358-368
320. Heiss W.D. Herholz K. Bocher-Schwarz H.G. et al. PET, CT, and MR imaging in cerebrovascular disease J. Comput. Assist. Tomogr. 10 1986 903-911
321. Uemura K. Shishido F. Higano S. et al. Positron emission tomography in patients with a primary intracerebral hematoma Acta Radiol. Suppl. 369 1986 426-428
322. Ishikawa T. Kawamura S. Hadeishi H. et al. Uncoupling between CBF and oxygen metabolism in a patient with chronic subdural haematoma: case report J. Neurol. Neurosurg. Psychiatry. 55 1992 401-403
323. Ishikawa T. Kawamura S. Hadeishi H. et al. Cerebral blood flow and oxygen metabolism in hemiparetic patients with chronic subdural hematoma. Quantitative evaluation using positron emission tomography Surg. Neurol. 43 1995 130-136
324. Zazulia A.R. Diringer M.N. Videen T.O. et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage J. Cereb. Blood Flow Metab. 21 2001 804-810
325. Ogawa T. Hatazawa J. Inugami A. et al. Carbon-11-methionine PET evaluation of intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma J. Nucl. Med. 36 1995 2175-2179
326. Hino A. Mizukawa N. Tenjin H. et al. Postoperative hemodynamic and metabolic changes in patients with subarachnoid hemorrhage Stroke 20 1989 1504-1510
327. Carpenter D.A. Grubb R.L. Jr. Tempel L.W. Powers W.J. Cerebral oxygen metabolism after aneurysmal subarachnoid hemorrhage J. Cereb. Blood Flow Metab. 11 1991 837-844
328. Hayashi T. Suzuki A. Hatazawa J. et al. Cerebral circulation and metabolism in the acute stage of subarachnoid hemorrhage J. Neurosurg. 93 2000 1014-1018
329. Feeney D.M. Baron J.C. Diaschisis [Review] Stroke 17 1986 817-830
330. Baron J.C. Bousser M.G. Comar D. et al. Crossed cerebellar diaschisis in human supratentorial brain infarction Trans. Am. Neurol. Assoc. 105 1980 459-461
331. De Reuck J. Decoo D. Lemahieu I. et al. Crossed cerebellar diaschisis after middle cerebral artery infarction Clin. Neurol. Neurosurg. 99 1997 11-16
332. Jacobs A. Herholz K. Pietrzyk U. et al. Diaschisis of specific cerebellar lobules: pontine haematoma studied with high-resolution PET and MRI J. Neurol. 243 1996 131-136
333. Kushner M. Alavi A. Reivich M. et al. Contralateral cerebellar hypometabolism following cerebral insult: a positron emission tomographic study Ann. Neurol. 15 1984 425-434
334. Miura H. Nagata K. Hirata Y. et al. Evolution of crossed cerebellar diaschisis in middle cerebral artery infarction J. Neuroimaging. 4 1994 91-96
335. Yamauchi H. Fukuyama H. Nagahama Y. Okazawa H. Konishi J. A decrease in regional cerebral blood volume and hematocrit in crossed cerebellar diaschisis Stroke 30 1999 1429-1431
336. Fulham M.J. Brooks R.A. Hallett M. Di Chiro G. Cerebellar diaschisis revisited: pontine hypometabolism and dentate sparing Neurology. 42 1992 2267-2273
337. Shamoto H. Chugani H.T. Glucose metabolism in the human cerebellum: an analysis of crossed cerebellar diaschisis in children with unilateral cerebral injury J. Child Neurol. 12 1997 407-414
338. Ito H. Kanno I. Shimosegawa E. et al. Hemodynamic changes during neural deactivation in human brain: a positron emission tomography study of crossed cerebellar diaschisis Ann. Nucl. Med. 16 2002 249-254
339. Brunberg J.A. Frey K.A. Horton J.A. Kuhl D.E. Crossed cerebellar diaschisis - Occurence and resolution demonstrated with PET during carotid temporary occlusion AJNR: Am. J. Neuroradiol. 13 1992 58-61
340. Dettmers C. Hartmann A. Rommel T. et al. Contralateral cerebellar diaschisis 7 hours after MCA-occlusion in primates Neurol. Res. 17 1995 109-112
341. Pawlik G. Herholz K. Beil C. et al. Remote effects of focal lesions on cerebral blood flow and metabolism in: Heiss W.D. (Ed.), Functional mapping of the brain in vascular disorders 1985 59-84 Springer Berlin
342. Pantano P. Formisano R. Ricci M. et al. Prolonged muscular flaccidity in stroke patients is associated with crossed cerebellar diaschisis Cerebrovasc. Dis. 3 1993 80-85
343. Pantano P. Baron J.C. Samson Y. et al. Crossed cerebellar diaschisis. Further studies Brain 109 1986 677-694
344. Tanaka M. Kondo S. Hirai S. et al. Crossed cerebellar diaschisis accompanied by hemiataxia: a PET study J. Neurol. Neurosurg. Psychiatry. 55 1992 121-125
345. Tecco J.M. Wuilmart P. Lasseaux L. et al. Cerebello-thalamo-cerebral diaschisis: a case report J. Neuroimaging. 8 1998 115-116
346. Niimura K. Chugani D.C. Muzik O. Chugani H.T. Cerebellar reorganization following cortical injury in humans: effects of lesion size and age Neurology 52 1999 792-797
347. Szelies B. Herholz K. Pawlik G. et al. Widespread functional effects of discrete thalamic infarction Arch. Neurol. 48 1991 178-182
348. Baron J.C. D'Antona R. Pantano P. et al. Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man Brain 109 1986 1243-1259
349. Chabriat H. Pappata S. Levasseur M. et al. Cortical metabolism in posterolateral thalamic stroke: PET study Acta Neurol. Scand. 86 1992 285-290
350. Baron J.C. Levasseur M. Mazoyer B. et al. Thalamocortical diaschisis: positron emission tomography in humans J. Neurol. Neurosurg. Psychiatry. 55 1992 935-942
351. Pappata S. Mazoyer B. Tran Dinh S. et al. Effects of capsular or thalamic stroke on metabolism in the cortex and cerebellum: a positron tomography study Stroke 21 1990 519-524
352. Iglesias S. Marchal G. Viader F. Baron J.C. Delayed intrahemispheric remote hypometabolism. Correlations with early recovery after stroke Cerebrovasc. Dis. 10 2000 391-402
353. Dobkin J.A. Levine R.L. Lagreze H.L. et al. Evidence for transhemispheric diaschisis in unilateral stroke Arch Neurol. 46 1989 1333-1336
354. Lagreze H.L. Levine R.L. Pedula K.L. et al. Contralateral flow reduction in unilateral stroke: evidence for transhemispheric diaschisis Stroke 18 1987 882-886
355. Shishido F. Uemura K. Inugami A. et al. Remote effects in MCA territory ischemic infarction: a study of regional cerebral blood flow and oxygen metabolism using positron computed tomography and 15O labeled gases Radiat. Med. 5 1987 36-41
356. Pawlik G. Wienhard K. Herholz K. Wagner R. Heiss W.D. Positron emission tomography study of regional glucose metabolism in cerebral ischemia-topographic and kinetic aspects Prog. Brain Res. 62 1984 253-262
357. Cappa S.F. Perani D. Grassi F. et al. A PET follow-up study of recovery after stroke in acute aphasics Brain Lang. 56 1997 55-67
358. Seitz R.J. Azari N.P. Knorr U. et al. The role of diaschisis in stroke recovery Stroke 30 1999 1844-1850
359. Baron J.C. Depression of energy metabolism in distant brain structures: studies with positron emission tomography in stroke patients Semin. Neurol. 9 1989 281-285
360. Fink G.R. Pietrzyk U. Herholz K. Huber M. Heiss W.D. Functional and morphological imaging of small striato-capsular infarction by CT, MRI and multitracer PET Neurol. Res. 14 1992 139-142
361. Powers W.J. Press G.A. Grubb R.L. Jr. Gado M. Raichle M.E. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation Ann. Intern. Med. 106 1987 27-34
362. Gibbs J.M. Wise R.J.S. Leenders K.L. Jones T. Evaluation of cerebral perfusion reserve in patients with carotid artery occlusion Lancet I 1984 310-314
363. Yamauchi H. Fukuyama H. Nagahama Y. et al. Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET J. Neurol. Neurosurg. Psychiatry. 61 1996 18-25
364. Pozzilli C. Itoh M. Matsuzawa T. et al. Positron emission tomography in minor ischemic stroke using oxygen-15 steady-state technique J. Cereb. Blood Flow Metab. 7 1987 137-142
365. Powers W.J. Derdeyn C.P. Fritsch S.M. et al. Benign prognosis of never-symptomatic carotid occlusion Neurology 54 2000 878-882
366. Derdeyn C.P. Videen T.O. Yundt K.D. et al. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited Brain 125 2002 595-607
367. Herholz K. Heiss W.-D. Functional imaging correlates of recovery after stroke in humans J. Cereb. Blood Flow Metab. 20 2000 1619-1631
368. Heiss W.D. Emunds H.G. Herholz K. Cerebral glucose metabolism as a predictor of rehabilitation after ischemic stroke Stroke 24 1993 1784-1788
369. Müller R.A. Chugani H.T. Muzik O. Mangner T.J. Brain organization of motor and language functions following hemispherectomy: a [(15)O]-water positron emission tomography study J. Child Neurol. 13 1998 16-22
370. Chugani H.T. Jacobs B. Metabolic recovery in caudate nucleus of children following cerebral hemispherectomy Ann. Neurol. 36 1994 794-797
371. Nakayama H. Jorgensen H.S. Raaschou H.O. Olsen T.S. The influence of age on stroke outcome. The Copenhagen Stroke Study Stroke 25 1994 808-813
372. Metter E.J. Hanson W.R. Jackson C.A. et al. Temporoparietal cortex in aphasia. Evidence from positron emission tomography Arch. Neurol. 47 1990 1235-1238
373. Karbe H. Herholz K. Szelies B. et al. Regional metabolic correlates of Token test results in cortical and subcortical left hemispheric infarction Neurology 39 1989 1083-1088
374. Metter E.J. Riege W.H. Hanson W.R. et al. Subcortical structures in aphasia. An analysis based on (F-18)- fluorodeoxyglucose, positron emission tomography, and computed tomography Arch. Neurol. 45 1988 1229-1234
375. Kumar R. Masih A.K. Pardo J. Global aphasia due to thalamic hemorrhage: a case report and review of the literature [Review] Arch. Phys. Med. Rehabil. 77 1996 1312-1315
376. Heiss W.D. Kessler J. Karbe H. Fink G.R. Pawlik G. Cerebral glucose metabolism as a predictor of recovery from aphasia in ischemic stroke Arch. Neurol. 50 1993 958-964
377. Karbe H. Kessler J. Herholz K. Fink G.R. Heiss W.D. Long-term prognosis of poststroke aphasia studied with positron emission tomography Arch. Neurol. 52 1995 186-190
378. Heiss W.D. Kessler J. Thiel A. Ghaemi M. Karbe H. Differential capacity of left and right hemispheric areas for compensation of poststroke aphasia Ann. Neurol. 45 1999 430-438
379. Warburton E. Price C.J. Swinburn K. Wise R.J. Mechanisms of recovery from aphasia: evidence from positron emission tomography studies [see comments] J. Neurol. Neurosurg. Psychiatry. 66 1999 155-161
380. Belin P. Vaneeckhout P. Zilbovicius M. et al. Recovery from nonfluent aphasia after melodic intonation therapy - a PET study Neurology 47 1996 1504-1511
381. Kessler J. Thiel A. Karbe H. Heiss W.D. Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients Stroke 31 2000 2112-2116
382. Ohyama M. Senda M. Kitamura S. et al. Role of the nondominant hemisphere and undamaged area during word repetition in poststroke aphasics. A PET activation study Stroke 27 1996 897-903
383. Weiller C. Isensee C. Rijntjes M. et al. Recovery from Wernicke's aphasia: a positron emission tomographic study Ann. Neurol. 37 1995 723-732
384. Musso M. Weiller C. Kiebel S. et al. Training-induced brain plasticity in aphasia Brain 122 1999 1781-1790
385. Karbe H. Thiel A. Weber-Luxenburger G. et al. Brain plasticity in poststroke aphasia: what is the contribution of the right hemisphere? Brain Lang. 64 1998 215-230
386. Weiller C. Chollet F. Friston K.J. Wise R.J. Frackowiak R.S. Functional reorganization of the brain in recovery from striatocapsular infarction in man Ann. Neurol. 31 1992 463-472
387. Weder B. Knorr U. Herzog H. et al. Tactile exploration of shape after subcortical ischaemic infarction studied with PET Brain 117 1994 593-605
388. Nelles G. Spiekermann G. Jueptner M. et al. Reorganization of sensory and motor systems in hemiplegic stroke patients: A positron emission tomography study Stroke 30 1999 1510-1516
389. Seitz R.J. Hoflich P. Binkofski F. et al. Role of the premotor cortex in recovery from middle cerebral artery infarction Arch. Neurol. 55 1998 1081-1088
390. Jenkins I.H. Brooks D.J. Nixon P.D. Frackowiak R.S. Passingham R.E. Motor sequence learning: a study with positron emission tomography J. Neurosci. 14 1994 3775-3790
391. Schlaug G. Knorr U. Seitz R. Inter-subject variability of cerebral activations in acquiring a motor skill: a study with positron emission tomography Exp. Brain Res. 98 1994 523-534
392. Rauch S.L. Savage C.R. Brown H.D. et al. A PET investigation of implicit and explicit sequence learning Hum. Brain Mapp. 3 1995 271-286
393. Chollet F. DiPiero V. Wise R.J. et al. The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography Ann. Neurol. 29 1991 63-71
394. Honda M. Nagamine T. Fukuyama H. et al. Movement-related cortical potentials and regional cerebral blood flow change in patients with stroke after motor recovery J. Neurol. Sci. 146 1997 117-126
395. Cramer S.C. Nelles G. Benson R.R. et al. A functional MRI study of subjects recovered from hemiparetic stroke Stroke 28 1997 2518-2527
396. Weiller C. Ramsay S.C. Wise R.J. Friston K.J. Frackowiak R.S. Individual patterns of functional reorganization in the human cerebral cortex after capsular infarction Ann. Neurol. 33 1993 181-189
397. Calautti C. Baron J.C. Functional neuroimaging studies of motor recovery after stroke in adults: a review Stroke 34 2003 1553-1566
398. Calautti C. Leroy F. Guincestre J.Y. Marie R.M. Baron J.C. Sequential activation brain mapping after subcortical stroke: changes in hemispheric balance and recovery Neuroreport 12 2001 3883-3886
399. Weder B. Seitz R.J. Deficient cerebral activation pattern in stroke recovery Neuroreport 5 1994 457-460
400. Iglesias S. Marchal G. Rioux P. et al. Do changes in oxygen metabolism in the unaffected cerebral hemisphere underlie early neurological recovery after stroke? - A positron emission tomography study Stroke 27 1996 1192-1199
401. Binkofski F. Seitz R.J. Arnold S. et al. Thalamic metabolism and corticospinal tract integrity determine motor recovery in stroke Ann. Neurol. 39 1996 460-470
402. Azari N.P. Binkofski F. Pettigrew K.D. Freund H.J. Seitz R.J. Enhanced regional cerebral metabolic interactions in thalamic circuitry predicts motor recovery in hemiparetic stroke Hum. Brain Mapp. 4 1996 240-253
403. Neuroimaging Subcommission of the International League Against Epilepsy Commission on Diagnostic Strategies: recommendations for functional neuroimaging of persons with epilepsy [In Process Citation] Epilepsia 41 2000 1350-1356
404. European Federation of Neurological Societies Task Force Pre-surgical evaluation for epilepsy surgery-European standards Eur. J. Neurol. 7 2000 119-122
405. Kuzniecky R.I. Knowlton R.C. Neuroimaging of epilepsy Semin. Neurol. 22 2002 279-288
406. Kuhl D.E. Engel J. Jr. Phelps M.E. Selin C. Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3 Ann. Neurol. 8 1980 348-360
407. Engel J. Jr. Kuhl D.E. Phelps M.E. Patterns of human local cerebral glucose metabolism during epileptic seizures Science 218 1982 64-66
408. Engel J. Jr. Brown W.J. Kuhl D.E. et al. Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy Ann. Neurol. 12 1982 518-528
409. Breier J.I. Mullani N.A. Thomas A.B. et al. Effects of duration of epilepsy on the uncoupling of metabolism and blood flow in complex partial seizures Neurology 48 1997 1047-1053
410. Debets R.M. Sadzot B. van Isselt J.W. et al. Is 11C-flumazenil PET superior to 18FDG-PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? J. Neurol. Neurosurg. Psychiatry 62 1997 141-150
411. Lamusuo S. Ruottinen H.M. Knuuti J. et al. Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex J. Neurol. Neurosurg. Psychiatry 63 1997 743-748
412. Henry T.R. Mazziotta J.C. Engel J. Jr. Interictal metabolic anatomy of mesial temporal lobe epilepsy Arch. Neurol. 50 1993 582-589
413. Sackellares J.C. Siegel G.J. Abou-Khalil B.W. et al. Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin Neurology 40 1990 1420-1426
414. Kim Y.K. Lee D.S. Lee S.K. et al. Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG-PET Using SPM J. Nucl. Med. 44 2003 1006-1012
415. Rausch R. Henry T.R. Ary C.M. Engel J. Jr. Mazziotta J. Asymmetric interictal glucose hypometabolism and cognitive performance in epileptic patients Arch. Neurol. 51 1994 139-144
416. Vielhaber S. Von Oertzen J.H. Kudin A.F. et al. Correlation of hippocampal glucose oxidation capacity and interictal FDG-PET in temporal lobe epilepsy Epilepsia 44 2003 193-199
417. Pfund Z. Chugani D.C. Juhasz C. et al. Evidence for coupling between glucose metabolism and glutamate cycling using FDG-PET and 1H magnetic resonance spectroscopy in patients with epilepsy J. Cereb. Blood Flow Metab. 20 2000 871-878
418. Knowlton R.C. Abou-Khalil B. Sawrie S.M. et al. In vivo hippocampal metabolic dysfunction in human temporal lobe epilepsy Arch. Neurol. 59 2002 1882-1886
419. Peyron R. Cinotti L. Le Bars D. et al. Effects of GABAA receptors activation on brain glucose metabolism in normal subjects and temporal lobe epilepsy (TLE) patients. A positron emission tomography (PET) study: Part II: The focal hypometabolism is reactive to GABAA agonist administration in TLE Epilepsy Res. 19 1994 55-62
420. Cornford E.M. Hyman S. Cornford M.E. Landaw E.M. Delgado-Escueta A.V. Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier J. Cereb. Blood Flow Metab. 18 1998 26-42
421. Bittar R.G. Andermann F. Olivier A. et al. Interictal spikes increase cerebral glucose metabolism and blood flow: a PET study Epilepsia 40 1999 170-178
422. Theodore W.H. Gaillard W.D. De Carli C. Bhatia S. Hatta J. Hippocampal volume and glucose metabolism in temporal lobe epileptic foci Epilepsia 42 2001 130-132
423. Foldvary N. Lee N. Hanson M.W. et al. Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy Epilepsia 40 1999 26-29
424. Diehl B. LaPresto E. Najm I. et al. Neocortical temporal FDG-PET hypometabolism correlates with temporal lobe atrophy in hippocampal sclerosis associated with microscopic cortical dysplasia Epilepsia 44 2003 559-564
425. Bouilleret V. Dupont S. Spelle L. et al. Insular cortex involvement in mesiotemporal lobe epilepsy: A positron emission tomography study Ann. Neurol. 51 2002 202-208
426. Dupont S. Semah F. Baulac M. Samson Y. The underlying pathophysiology of ictal dystonia in temporal lobe epilepsy: an FDG-PET study Neurology 51 1998 1289-1292
427. Schlaug G. Antke C. Holthausen H. et al. Ictal motor signs and interictal regional cerebral hypometabolism J. Cereb. Blood Flow Metab. 17 1997 740-744
428. Rosenow F. Luders H. Presurgical evaluation of epilepsy Brain 124 2001 1683-1700
429. Wunderlich G. Schuller M.F. Ebner A. et al. Temporal lobe epilepsy with sensory aura: interictal glucose hypometabolism Epilepsy Res. 38 2000 139-149
430. Dlugos D.J. Jaggi J. O'Connor W.M. et al. Hippocampal cell density and subcortical metabolism in temporal lobe epilepsy Epilepsia 40 1999 408-413
431. Pawlik G. Holthoff V.A. Kessler J. et al. Positron emission tomography findings relevant to neurosurgery for epilepsy Acta Neurochir. 50 Suppl. 1990 84-87
432. Pawlik G. Fink G.R. Kessler J. Heiss W.D. PET and functional testing in temporal lobe epilepsy Acta Neurol. Scand. 15 Suppl. 1994 150-156
433. Bromfield E.B. Ludlow C.L. Sedory S. Leiderman D.B. Theodore W.H. Cerebral activation during speech discrimination in temporal lobe epilepsy Epilepsy Res. 9 1991 49-58
434. Choi J.Y. Kim S.J. Hong S.B. et al. Extratemporal hypometabolism on FDG-PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy Eur. J. Nucl. Med. Mol. Imaging. 30 2003 581-587
435. Blum D.E. Ehsan T. Dungan D. Karis J.P. Fisher R.S. Bilateral temporal hypometabolism in epilepsy Epilepsia. 39 1998 651-659
436. Manno E.M. Sperling M.R. Ding X. et al. Predictors of outcome after anterior temporal lobectomy: positron emission tomography Neurology. 44 1994 2331-2336
437. Newberg A.B. Alavi A. Berlin J. et al. Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures J. Nucl. Med. 41 2000 1964-1968
438. Spanaki M.V. Kopylev L. DeCarli C. et al. Postoperative changes in cerebral metabolism in temporal lobe epilepsy Arch. Neurol. 57 2000 1447-1452
439. Dasheiff R.M. Rosenbek J. Matthews C. et al. Epilepsy surgery improves regional glucose metabolism on PET scan. A case report J. Neurol. 234 1987 283-288
440. DellaBadia J. Jr. Bell W.L. Keyes J.W. Jr. Mathews V.P. Glazier S.S. Assessment and cost comparison of sleep-deprived EEG, MRI and PET in the prediction of surgical treatment for epilepsy Seizure 11 2002 303-309
441. Theodore W.H. When is positron emission tomography really necessary in epilepsy diagnosis? Curr. Opin. Neurol. 15 2002 191-195
442. Meyer P.T. Cortes-Blanco A. Pourdehnad M. et al. Inter-modality comparisons of seizure focus lateralization in complex partial seizures Eur. J. Nucl. Med. 28 2001 1529-1540
443. Lamusuo S. Jutila L. Ylinen A. [18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage Arch. Neurol. 58 2001 933-939
444. Hwang S.I. Kim J.H. Park S.W. et al. Comparative analysis of MR imaging, positron emission tomography, and ictal single-photon emission CT in patients with neocortical epilepsy AJNR Am. J. Neuroradiol. 22 2001 937-946
445. Stefan H. Pawlik G. Bocher-Schwarz H.G. et al. Functional and morphological abnormalities in temporal lobe epilepsy: a comparison of interictal and ictal EEG, CT, MRI, SPECT and PET J. Neurol. 234 1987 377-384
446. O'Brien T.J. Hicks R.J. Ware R. et al. The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal-based PET scanner in the presurgical evaluation of partial epilepsy J. Nucl. Med. 42 2001 1158-1165
447. Richardson M.P. Koepp M.J. Brooks D.J. Duncan J.S. 11C-flumazenil PET in neocortical epilepsy Neurology 51 1998 485-492
448. Muzik O. Da Silva E.A. Juhasz C. et al. Intracranial EEG vs. flumazenil and glucose PET in children with extratemporal lobe epilepsy Neurology 54 2000 171-179
449. Franck G. Maquet P. Sadzot B. et al. Contribution of positron emission tomography to the investigation of epilepsies of frontal lobe origin Adv. Neurol. 57 1992 471-485
450. Theodore W.H. Gaillard W.D. Positron emission tomography in neocortical epilepsies Adv. Neurol. 84 2000 435-446
451. Swartz B.E. Halgren E. Delgado-Escueta A.V. et al. Neuroimaging in patients with seizures of probable frontal lobe origin Epilepsia 30 1989 547-558
452. Henry T.R. Sutherling W.W. Engel J. Jr. et al. Interictal cerebral metabolism in partial epilepsies of neocortical origin Epilepsy Res. 10 1991 174-182
453. Ryvlin P. Bouvard S. Le Bars D. et al. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients Brain 121 1998 2067-2081
454. Swartz B.W. Khonsari A. Vrown C. et al. Improved sensitivity of 18FDG-positron emission tomography scans in frontal and "frontal plus" epilepsy Epilepsia 36 1995 388-395
455. Da Silva E.A. Chugani D.C. Muzik O. Chugani H.T. Identification of frontal lobe epileptic foci in children using positron emission tomography Epilepsia 38 1997 1198-1208
456. Savic I. Persson A. Roland P. et al. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci Lancet 2 1988 863-866
457. Nagy F. Chugani D.C. Juhasz C. et al. Altered in vitro and in vivo flumazenil binding in human epileptogenic neocortex J. Cereb. Blood Flow Metab. 19 1999 939-947
458. Koepp M.J. Richardson M.P. Labbe C. et al. C-11-Flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy Neurology 49 1997 764-773
459. Juhasz C. Nagy F. Muzik O. et al. [11C]Flumazenil PET in patients with epilepsy with dual pathology Epilepsia 40 1999 566-574
460. Lamusuo S. Pitkanen A. Jutila L. et al. [11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology Neurology 54 2000 2252-2260
461. Koepp M.J. Hammers A. Labbe C. et al. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI Neurology 54 2000 332-339
462. Szelies B. Weber-Luxenburger G. Mielke R. et al. Interictal hippocampal benzodiazepine receptors in temporal lobe epilepsy: comparison with coregistered hippocampal metabolism and volumetry Eur. J. Neurol. 7 2000 393-400
463. Savic I. Ingvar M. Stone-Elander S. Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci J. Neurol. Neurosurg. Psychiatry. 56 1993 615-621
464. Szelies B. Sobesky J. Pawlik G. et al. Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic epilepsies studied by [11C]-flumazenil PET Eur. J. Neurol. 9 2002 137-142
465. Hammers A. Koepp M.J. Labbe C. et al. Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy Neurology 56 2001 897-906
466. Arnold S. Berthele A. Drzezga A. et al. Reduction of benzodiazepine receptor binding is related to the seizure onset zone in extratemporal focal cortical dysplasia Epilepsia 41 2000 818-824
467. Savic I. Svanborg E. Thorell J.O. Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study Epilepsia 37 1996 236-244
468. Juhasz C. Chugani D.C. Muzik O. et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome Neurology 56 2001 1650-1658
469. Juhasz C. Chugani D.C. Muzik O. et al. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy Neurology 55 2000 825-835
470. Richardson M.P. Hammers A. Brooks D.J. Duncan J.S. Benzodiazepine-GABA(A) receptor binding is very low in dysembryoplastic neuroepithelial tumor: a PET study Epilepsia 42 2001 1327-1334
471. Hammers A. Koepp M.J. Richardson M.P. et al. Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients Brain 126 2003 1300-1318
472. Hammers A. Koepp M.J. Richardson M.P. et al. Central benzodiazepine receptors in malformations of cortical development: A quantitative study Brain 124 2001 1555-1565
473. Miura K. Watanabe K. Maeda N. et al. Magnetic resonance imaging and positron emission tomography of band heterotopia Brain Dev. 15 1993 288-290
474. De Volder A.G. Gadisseux J.F. Michel C.J. et al. Brain glucose utilization in band heterotopia: synaptic activity of "double cortex." Pediatr Neurol. 11 1994 290-294
475. Bairamian D. Di Chiro G. Theodore W.H. et al. MR imaging and positron emission tomography of cortical heterotopia J. Comput. Assist. Tomogr. 9 1985 1137-1139
476. Falconer J. Wada J.A. Martin W. Li D. PET, CT, and MRI imaging in neuronal migration anomalies in epileptic patients Can. J. Neurol. Sci. 17 1990 35-39
477. Müller R.A. Behen M.E. Muzik O. et al. Task-related activations in heterotopic brain malformations: a PET study Neuroreport 9 1998 2527-2533
478. Richardson M.P. Koepp M.J. Brooks D.J. et al. Cerebral activation in malformations of cortical development Brain 121 1998 1295-1304
479. Kameyama S. Fukuda M. Tomikawa M. et al. Surgical strategy and outcomes for epileptic patients with focal cortical dysplasia or dysembryoplastic neuroepithelial tumor Epilepsia 42 Suppl. 6 2001 37-41
480. Sasaki M. Kuwabara Y. Yoshida T. et al. Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG-PET and technetium-99m-ECD SPECT J. Nucl. Med. 39 1998 974-977
481. Chugani H.T. Chugani D.C. Basic mechanisms of childhood epilepsies: studies with positron emission tomography Adv. Neurol. 79 1999 883-891
482. Juhasz C. Chugani H.T. Muzik O. Chugani D.C. Neuroradiological assessment of brain structure and function and its implication in the pathogenesis of West syndrome Brain Dev. 23 2001 488-495
483. Chugani H.T. Mazziotta J.C. Engel J. Jr. Phelps M.E. The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography Ann. Neurol. 21 1987 4-13
484. Theodore W.H. Rose D. Patronas N. et al. Cerebral glucose metabolism in the Lennox-Gastaut syndrome Ann. Neurol. 21 1987 14-21
485. Ferrie C.D. Marsden P.K. Maisey M.N. Robinson R.O. Cortical and subcortical glucose metabolism in childhood epileptic encephalopathies J. Neurol. Neurosurg. Psychiatry 63 1997 181-187
486. Olson D.M. Chugani H.T. Shewmon D.A. Phelps M.E. Peacock W.J. Electrocorticographic confirmation of focal positron emission tomographic abnormalities in children with intractable epilepsy Epilepsia 31 1990 731-739
487. Maquet P. Hirsch E. Dive D. et al. Cerebral glucose utilization during sleep in Landau-Kleffner syndrome: a PET study Epilepsia 31 1990 778-783
488. Da Silva E.A. Chugani D.C. Muzik O. Chugani H.T. Landau-Kleffner syndrome: metabolic abnormalities in temporal lobe are a common feature J. Child Neurol. 12 1997 489-495
489. Rintahaka P.J. Chugani H.T. Sankar R. Landau-Kleffner syndrome with continuous spikes and waves during slow-wave sleep J. Child Neurol. 10 1995 127-133
490. Majerus S. Laureys S. Collette F. et al. Phonological short-term memory networks following recovery from Landau and Kleffner syndrome Hum. Brain Mapp. 19 2003 133-144
491. Maquet P. Hirsch E. Metzlutz M.N. et al. Regional cerebral glucose metabolism in children with deterioration of one or more cognitive functions and continuous spike-and-wave discharges during sleep Brain 118 1995 1497-1520
492. Muller R.A. Chugani H.T. Muzik O. Mangner T.J. Brain organization of motor and language functions following hemispherectomy: a [(15)O]-water positron emission tomography study J. Child Neurol. 13 1998 16-22